Covigilant Research, LLC Clinical Trials Site Management Organization

Covigilant Research, LLC

Committed To Working Together

FDA limits J&J COVID-19 vaccine due to rare blood clot risk – ABC News

The Food and Drug Administration has limited its authorization of the Johnson & Johnson COVID-19 vaccine due to the rare risk of blood clots.Read MoreThe Food and Drug Administration has limited its authorization of the Johnson & Johnson COVID-19 vaccine due to the rare risk of blood clots.

Scroll to Top